Cargando…

Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy

Detalles Bibliográficos
Autores principales: Wang, Xing, Yin, Guobing, Zhang, Wei, Song, Kunling, Zhang, Longbin, Guo, Zufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250026/
https://www.ncbi.nlm.nih.gov/pubmed/37305537
http://dx.doi.org/10.3389/fphar.2023.1220144
_version_ 1785055665191911424
author Wang, Xing
Yin, Guobing
Zhang, Wei
Song, Kunling
Zhang, Longbin
Guo, Zufeng
author_facet Wang, Xing
Yin, Guobing
Zhang, Wei
Song, Kunling
Zhang, Longbin
Guo, Zufeng
author_sort Wang, Xing
collection PubMed
description
format Online
Article
Text
id pubmed-10250026
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-102500262023-06-09 Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy Wang, Xing Yin, Guobing Zhang, Wei Song, Kunling Zhang, Longbin Guo, Zufeng Front Pharmacol Pharmacology Frontiers Media S.A. 2023-05-25 /pmc/articles/PMC10250026/ /pubmed/37305537 http://dx.doi.org/10.3389/fphar.2023.1220144 Text en Copyright © 2023 Wang, Yin, Zhang, Song, Zhang and Guo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Xing
Yin, Guobing
Zhang, Wei
Song, Kunling
Zhang, Longbin
Guo, Zufeng
Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
title Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
title_full Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
title_fullStr Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
title_full_unstemmed Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
title_short Corrigendum: Prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
title_sort corrigendum: prostaglandin reductase 1 as a potential therapeutic target for cancer therapy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250026/
https://www.ncbi.nlm.nih.gov/pubmed/37305537
http://dx.doi.org/10.3389/fphar.2023.1220144
work_keys_str_mv AT wangxing corrigendumprostaglandinreductase1asapotentialtherapeutictargetforcancertherapy
AT yinguobing corrigendumprostaglandinreductase1asapotentialtherapeutictargetforcancertherapy
AT zhangwei corrigendumprostaglandinreductase1asapotentialtherapeutictargetforcancertherapy
AT songkunling corrigendumprostaglandinreductase1asapotentialtherapeutictargetforcancertherapy
AT zhanglongbin corrigendumprostaglandinreductase1asapotentialtherapeutictargetforcancertherapy
AT guozufeng corrigendumprostaglandinreductase1asapotentialtherapeutictargetforcancertherapy